State Of New Jersey Common Pension Fund D Prothena Corp Public LTD CO Transaction History

State Of New Jersey Common Pension Fund D

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$47.3 - $70.6 $467,655 - $698,022	9,887 Added 27.41%	45,952 $2.22 Million
Q2 2023 Aug 02, 2023	SELL	$48.26 - $78.59 $409,920 - $667,543	-8,494 Reduced 19.06%	36,065 $2.46 Million
Q1 2023 Apr 26, 2023	BUY	$46.97 - $58.27 $326,864 - $405,500	6,959 Added 18.51%	44,559 $2.16 Million
Q4 2022 Feb 01, 2023	BUY	$52.05 - $65.0 $1.96 Million - $2.44 Million	37,600 New	37,600 $2.27 Million
Q1 2022 May 03, 2022	SELL	$30.27 - $49.22 $1.45 Million - $2.35 Million	-47,823 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$42.11 - $73.26 $138,205 - $240,439	3,282 Added 7.37%	47,823 $2.36 Million
Q3 2021 Oct 27, 2021	BUY	$48.2 - $78.89 $2.15 Million - $3.51 Million	44,541 New	44,541 $3.17 Million

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.